34.10
price down icon4.11%   -1.46
after-market Handel nachbörslich: 34.35 0.25 +0.73%
loading

Finanzdaten der Harrow Inc-Aktie (HROW)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
24.36%
89.09
71.64 63.74 47.83 66.83
Cost Of Revenue
4.27%
18.47
17.71 16.23 15.52 14.13
Gross Profit
30.96%
70.62
53.93 47.51 32.31 52.70
Operating Expenses
40.47%
55.03
39.18 36.10 43.54 39.80
Benefits Costs and Expenses
11.44%
78.69
70.62 58.75 - 60.57
Costs And Expenses
11.44%
78.69
70.62 58.75 59.06 60.57
Depreciation and Amortization
5.31%
0.464
0.49 0.496 0.465 0.468
Operating Income/Loss
5.72%
15.59
14.75 11.41 -11.23 12.90
Nonoperating Income/Loss
62.16%
-5.194
-13.73 -6.414 -6.548 -6.636
Income/Loss From Continuing Operations Before Tax
919.31%
10.40
1.02 4.995 47.83 6.263
Income/Loss From Continuing Operations After Tax
549.61%
6.626
1.02 4.995 -17.78 6.777
Net Income/Loss
549.61%
6.626
1.02 4.995 -17.78 6.777
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.54%
0.1723
37.15 36.79 35.83 0.0533
Diluted Average Shares
99.56%
0.1723
38.88 38.85 35.83 0.0533
Basic Earnings Per Share
500.00%
0.18
0.03 0.14 -0.50 0.19
Diluted Earnings Per Share
500.00%
0.18
0.03 0.13 -0.50 0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.94
price up icon 1.15%
drug_manufacturers_specialty_generic RGC
$23.23
price down icon 3.21%
drug_manufacturers_specialty_generic RDY
$14.13
price down icon 1.53%
$129.78
price up icon 1.57%
$13.51
price down icon 2.10%
$536.12
price up icon 0.62%
Kapitalisierung:     |  Volumen (24h):